Evidence map›Paper›PMID 27877210›Full record

ArticleJournal of Cancer2016

Victor Hugo Bermúdez-Morales, Geny Fierros-Zarate, Celina García-Meléndrez, Juan Manuel Alcocer-Gonzalez, Ausencio Morales-Ortega, Oscar Peralta-Zaragoza, Kirvis Torres-Poveda, Ana Isabel Burguete-García, Eva Hernández-Márquez, Vicente Madrid-Marina

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Victor Hugo Bermúdez-MoralesDivision of Chronic Infection and Cancer, National Institute of Public Health. Av. Universidad 655, Cuernavaca, Morelos. México. 62100.
Geny Fierros-ZarateDivision of Chronic Infection and Cancer, National Institute of Public Health. Av. Universidad 655, Cuernavaca, Morelos. México. 62100.
Celina García-MeléndrezBiotecnhgology Institute. National Autonomous University of Mexico, Cuernavaca Morelos, México.
Juan Manuel Alcocer-GonzalezSchool of Biological Sciences, Autonomous University of Nuevo León, Monterrey, México.
Ausencio Morales-OrtegaDivision of Chronic Infection and Cancer, National Institute of Public Health. Av. Universidad 655, Cuernavaca, Morelos. México. 62100.
Oscar Peralta-ZaragozaDivision of Chronic Infection and Cancer, National Institute of Public Health. Av. Universidad 655, Cuernavaca, Morelos. México. 62100.
Kirvis Torres-PovedaDivision of Chronic Infection and Cancer, National Institute of Public Health. Av. Universidad 655, Cuernavaca, Morelos. México. 62100.
Ana Isabel Burguete-GarcíaDivision of Chronic Infection and Cancer, National Institute of Public Health. Av. Universidad 655, Cuernavaca, Morelos. México. 62100.
Eva Hernández-MárquezDivision of Chronic Infection and Cancer, National Institute of Public Health. Av. Universidad 655, Cuernavaca, Morelos. México. 62100.
Vicente Madrid-MarinaDivision of Chronic Infection and Cancer, National Institute of Public Health. Av. Universidad 655, Cuernavaca, Morelos. México. 62100.
Instituto Nacional de Salud Pública · MXUniversidad Autónoma del Estado de Morelos · MXUniversidad Autónoma de Nuevo León · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) is a DNA virus that infects epithelial cells and has been implicated in the development of cervical cancer. Few therapeutic strategies have been designed for the treatment of cervical intraepithelial neoplasia, a precursor of cervical cancer. In these early stages, the HPV E2 protein is the most important viral factor involved in viral gene expression and plays crucial roles during the vegetative viral cycle in epithelial cells. Papillomavirus E2 binds specifically to palindromic ACCN

Indexed as

adenovirusantitumor.gene therapyHPVHPV E2IL-12promoter

Identifiers

PMID27877210
PMCPMC5118658
OpenAlexW2551141511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.